Ladon, response mid-trained, PCA 128 + TabICL v2 (held-out trial response)
Mean-pooled embeddings of a response-mid-trained Ladon encoder reduced to 128 principal components and classified by TabICL v2 using labelled patients from academic cohorts and the other trials as in-context examples.
Overview
An explanatory profile has not yet been reviewed for this record.
Consult the linked sources for architecture or protocol details. Missing evidence is not evidence of a missing capability.
Model Capabilities & Hardware Requirements
Deployment facts recorded for Ladon, response mid-trained, PCA 128 + TabICL v2 (held-out trial response). Fields the record does not carry are marked not recorded.
Evaluated Checkpoint: Encoder after supervised mid-training that includes response labels from academic cohorts
Evaluations and results
1 evaluation · 1 result. Different protocols are not a single leaderboard.
Filter evaluations
Applied filters: All linked evaluations
| Tested configuration | Protocol and dataset | Finding | Evidence and details |
|---|---|---|---|
| Configuration: Ladon, response mid-trained, PCA 128 + TabICL v2 (held-out trial response) | Protocol: Held-out trials, immunotherapy response AUROC, equal mean over six trials Dataset subset: Immunotherapy arms of six held-out trials with evaluable response | 0.673 AUROC (AUROC for RECIST complete or partial response against other evaluable responses, immunotherapy arms, equal mean over six held-out trials) unitless · higher Uncertainty: Not reported by the source: Per-trial dots and a bar only; no interval is printed. Coverage: Not reported scored / Not reported eligible | Author-reported evaluation · Source checkedMethods, coverage and sourceLadon, held-out trials immunotherapy response AUROC ladon-20261115-protocol-trials-response-auroc Aggregation: Not reported Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Figure 6 (page 10), row 'Ladon', bar label |
Source checking is not independent reproduction. Release 2026-11-21-c8bea25e5abb.
Use this configuration
How it works, versions and access
Additional methodological details, versions and access terms have not yet been extracted into a structured profile for this configuration. Consult the linked sources and evaluation records below.
Evidence
Source checking verifies the cited claim or transcription. It does not establish independent reproduction.
Evidence table
Inspect claims, sources and review details
Trace each statement to its source and review. A context-only reference supports the record generally; it does not verify an individual field. Source checking does not reproduce an experiment.
One row per statement and cited source. Multiple citations are not independent evaluations. Shared locators are labelled explicitly.
0 evidence rows matching the loaded filters
| Property and statement | Original source and location | Review and provenance |
|---|
No evidence rows match these filters. Choose another scope or clear the search.
Sources and history
Release 2026-11-21-c8bea25e5abb · Record review: source checked
1 source record and release history
- Ladon: An RNA Foundation Model for Predicting Patient Outcomes (Zenodo PDF) · Original source · Zenodo record 24157116 (version DOI 10.5281/zenodo.24157116; concept DOI 10.5281/zenodo.24157115), file Ladon-An-RNA-Foundation-Model-for-Predicting-Patient-Outcomes.pdf, 47 pages, dated 12 November 2026
Technical metadata and record identifiers
Technical metadata for this record is tracked under stable ID ladon-20261115-config-ladon-response-tabicl.
Source locator: Pages 15 and 16, Methods 'Immunotherapy response'
Related records
- configuration of: Ladon
- subject: Ladon report: adaptation description conflict
- system: Ladon, held-out trials immunotherapy response AUROC
How to cite
Ladon, response mid-trained, PCA 128 + TabICL v2 (held-out trial response). Rewire biological model benchmark database, release 2026-11-21-c8bea25e5abb. https://benchmarks.rewirebio.io/database/configuration/ladon-20261115-config-ladon-response-tabicl/
Release 2026-11-21-c8bea25e5abb. Rankings and values change between releases, so keep the release id in the citation. Cite the original publication as well for any value you reuse: each result links its source.
The compilation and annotations made by Rewire in this release are offered under CC BY 4.0; values and text taken from cited sources stay under the terms of those sources and are not covered by this licence. Data licence